tiprankstipranks
iTeos Therapeutics participates in a conference call with JPMorgan
PremiumThe FlyiTeos Therapeutics participates in a conference call with JPMorgan
2M ago
Morning Movers: Bausch + Lomb surges as said to consider potential sale
Premium
The Fly
Morning Movers: Bausch + Lomb surges as said to consider potential sale
2M ago
iTeos Therapeutics Reports Positive Phase 2 Cancer Trial Results
Premium
Company Announcements
iTeos Therapeutics Reports Positive Phase 2 Cancer Trial Results
2M ago
iTeos Therapeutics announces first patient dosed in GALAXIES Lung-301 study
PremiumThe FlyiTeos Therapeutics announces first patient dosed in GALAXIES Lung-301 study
5M ago
iTeos Therapeutics, GSK initiate GALAXIES Lung-301 Phase 3 study
Premium
The Fly
iTeos Therapeutics, GSK initiate GALAXIES Lung-301 Phase 3 study
5M ago
iTeos Therapeutics (NASDAQ:ITOS): Harnessing the Power of Immunotherapy
Premium
Market News
iTeos Therapeutics (NASDAQ:ITOS): Harnessing the Power of Immunotherapy
6M ago
iTeos Therapeutics presents preclinical data on EOS-984
PremiumThe FlyiTeos Therapeutics presents preclinical data on EOS-984
8M ago
iTeos Therapeutics management to meet with Piper Sandler
Premium
The Fly
iTeos Therapeutics management to meet with Piper Sandler
8M ago
iTeos Therapeutics reports Q4 EPS (85c), consensus ($1.03)
Premium
The Fly
iTeos Therapeutics reports Q4 EPS (85c), consensus ($1.03)
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100